Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venrock
Biotech
Tubulis touts $361M series C as next-gen ADC data drop nears
As Tubulis prepares to unveil the first data on its next-gen ADC, the German biotech has mustered a sizeable new financing round.
Fraiser Kansteiner
Oct 15, 2025 5:01am
AIRNA preps for clinical test with $155M series B
Apr 1, 2025 7:00am
ADC biotech adds on $135M series B
Nov 25, 2024 7:00am
Paragon spinout Apogee makes debut with $169M
Dec 7, 2022 6:30am
Ocelot Bio gets a cool $36M series A and a new CEO to boot
Mar 23, 2022 8:30am